Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed...

Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston...

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma ( Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA )

Optimising immunoglobulin dosing can enhance patient outcomes in multiple...

Dr Elizabeth O'Donnell - Dana-Farber Cancer Institute, Boston, USA

Optimising immunoglobulin dosing can enhance patient outcomes in multiple myeloma ( Dr Elizabeth O'Donnell - Dana-Farber Cancer Institute, Boston, USA )

Oncologists' perspectives and practices on minimal residual disease testing in...

Dr Fathima Shehnaz Ayoobkhan - Internal Medicine Resident, Pontiac, USA

Oncologists' perspectives and practices on minimal residual disease testing in multiple myeloma ( Dr Fathima Shehnaz Ayoobkhan - Internal Medicine Resident, Pontiac, USA )

The need for improved healthcare infrastructure for extranodal NK/T-cell...

Dr Fabiola Valvert - INCAN, Guatemala City, Guatemala

The need for improved healthcare infrastructure for extranodal NK/T-cell lymphoma in Latin America ( Dr Fabiola Valvert - INCAN, Guatemala City, Guatemala )

Insights into germline genetic screening of breast cancer patients

Dr Teresa Ramón y Cajal, Dr Marjanka Schmidt and Dr Seigo Nakamura

Insights into germline genetic screening of breast cancer patients ( Dr Teresa Ramón y Cajal, Dr Marjanka Schmidt and Dr Seigo Nakamura )

Daratumumab and lenalidomide for frail patients with newly diagnosed multiple...

Prof Salomon Manier - Hospital Center University De Lille, Lille, France

Daratumumab and lenalidomide for frail patients with newly diagnosed multiple myeloma shows promising survival results ( Prof Salomon Manier - Hospital Center University De Lille, Lille, France )

High-fibre dietary intervention in precursor plasma cell disorders improves...

Dr Urvi Shah - Memorial Sloan Kettering Cancer Center, New York, USA

High-fibre dietary intervention in precursor plasma cell disorders improves biomarkers of disease, may delay progression to myeloma ( Dr Urvi Shah - Memorial Sloan Kettering Cancer Center, New York, USA )

Lack of benefit of auto-HCT in MCL patients in first complete remission with...

Dr Robert Dean - Cleveland Clinic Taussig Cancer Center, Cleveland, USA

Lack of benefit of auto-HCT in MCL patients in first complete remission with undetectable MRD ( Dr Robert Dean - Cleveland Clinic Taussig Cancer Center, Cleveland, USA )

SABCS 2024: Highlights in breast cancer genomic testing

Prof Matteo Lambertini and Prof Virginia Kaklamani

SABCS 2024: Highlights in breast cancer genomic testing ( Prof Matteo Lambertini and Prof Virginia Kaklamani )

Association between risk-reducing surgeries and survival in young BRCA carriers...

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

KRdc as induction therapy shows improved OS for NDMM patients

Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK

KRdc as induction therapy shows improved OS for NDMM patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )

Epcoritamab monotherapy is well tolerated and efficacious in patients with r/r...

Dr Alexey Danilov - City of Hope National Medical Center, Los Angeles, USA

Epcoritamab monotherapy is well tolerated and efficacious in patients with r/r CLL ( Dr Alexey Danilov - City of Hope National Medical Center, Los Angeles, USA )

More from ecancer